Zanamivir 5 mg | 99.86%
TargetMol

Zanamivir is a guanido-neuraminic acid that is used to inhibit NEURAMINIDASE.
More Information Supplier PageZanamivir is a guanido-neuraminic acid that is used to inhibit NEURAMINIDASE.
More Information Supplier PageZanamivir is a guanido-neuraminic acid that is used to inhibit NEURAMINIDASE.
More Information Supplier PageRegadenoson is an adenosine derivative and selective A2A adenosine receptor agonist with coronary vasodilating activity. Upon administration, regadenoson selectively binds to and activates the A2A adenosine receptor, which induces coronary vasodilation. This leads to an increase in coronary blood flow and enhances myocardial perfusion. Compared to adenosine, regadenoson has a longer half-life and shows higher […]
More Information Supplier PageKN-93 phosphate is a novel membrane-permeant synthetic inhibitor of purified neuronal CaMK-II with K i of 370 nM. KN-93 phosphate inhibits serum-induced fibroblast cell growth in a comparable dose-dependent fashion to its inhibition of CaMK-II activity.
More Information Supplier PageEtonogestrel is a steroidal progestin used as hormonal contraceptives.
More Information Supplier PageEtonogestrel is a steroidal progestin used as hormonal contraceptives.
More Information Supplier PageEtravirine is a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor. Etravirine is designed to be active against HIV isolates with mutations that confer resistance to the two most commonly prescribed first-generation NNRTIs. It can bind the enzyme reverse transcriptase (RT) in multiple conformations, both for native and mutant RT, thereby blocking the enzymatic activity of RT.
More Information Supplier PageEtravirine is a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor. Etravirine is designed to be active against HIV isolates with mutations that confer resistance to the two most commonly prescribed first-generation NNRTIs. It can bind the enzyme reverse transcriptase (RT) in multiple conformations, both for native and mutant RT, thereby blocking the enzymatic activity of RT.
More Information Supplier PageZanamivir is a guanido-neuraminic acid that is used to inhibit NEURAMINIDASE.
More Information Supplier PageQNZ46 is a NR2C/NR2D-selective NMDA receptor non-competitive antagonist.
More Information Supplier Page